SCHEMBL8338339

SCHEMBL8338339

CC1(C)CCCC2(C)C(N)CC12

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
CHRNB2 P17787 3/20 0.34
CHRNB4 P30926 3/20 0.34
CHRNA3 P32297 3/20 0.34
CHRNA4 P43681 3/20 0.34
TRPA1 O75762 1/20 0.34
PTPN1 P18031 3/20 0.33
CHRNA7 P36544 2/20 0.33
IDO1 P14902 1/20 0.33
CYP19A1 P11511 1/20 0.31
PTPN2 P17706 1/20 0.30
UGT2B7 P16662 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14412297 0.73 IDO1 (0.42) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL19214466 0.69
SCHEMBL14879929 0.69 PLA2G2A (0.40) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16011055 0.69 PLA2G2A (0.40) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL14879915 0.69 PLA2G2A (0.40) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL4692464 0.66 CYP3A4 (0.32) CYP3A4
SCHEMBL29866479 0.63 ALDH1A1 (0.57) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL29501291 0.62 PTPN1 (0.68) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL14879667 0.62 IDO1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL12793975 0.62 IDO1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2140864-A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods H.Lundbeck A/S (DK) 2010-01-06 EP disclosed
WO-2004014376-A1 GAL3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AFFECTIVE DISORDERS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-02-19 WO disclosed